According to a recent study, the estimated 12-month prevalence of medication-treated MDD in the United States was 8.9 million adults, and 2.8 million (30.9%) had TRD[Treatment Resistant Depression]. Different treatments and medications are available to treat common depression symptoms and those patients who find themselves dealing with treatment-resistant depression. In this blog, we’ll discuss tge differences between Ketamine infusion therapy vs esjetame nasal spray and which one may be the right choice for you or your loved ones.
Ktamine infusion therapy has been shown to be an effective treatment for patients who who have been diagnosed and are experiencing symptoms of PTSD, obsessive compulsive disorder (OCD), treatment-resistant depression, anxiety disorders, and suicidal ideation.
Ketamine infusion therapy is delivered intravenously (IV) to the patient during a prescribed period of time. by a licensed psychiatrist.
The benefits of ketamine infusion therapy vs esketamine nasal spreay include:
Esketamine nasal spray, known by its brand name Spravato, is a prescription medication that the FDA has approved for treating adults with treatment-resistant depression and depressive symptoms linked to major depressive disorder. It's often used in combination with an oral antidepressant.
This treatment is best suited for adults who are struggling with treatment-resistant depression and haven’t found relief from other antidepressants. It’s especially important for those who may be experiencing acute suicidal thoughts and can access a certified treatment center.
Patients can expect a quick reduction in depressive symptoms, a potential decrease in suicidal thoughts, a non-invasive nasal delivery method, and careful medical monitoring to ensure safety. Another benefit is that esketamine nasal spray fda approved.
Typically, the initial treatment consists of twice-weekly doses for four weeks. After that, patients enter a maintenance phase, which may involve weekly or biweekly treatments based on how they respond.
It’s primarily used to help adults dealing with treatment-resistant depression and the depressive symptoms that come with major depressive disorder, especially when other treatments haven’t worked.
Most insurance plans do cover Esketamine nasal spray, but keep in mind that coverage often requires prior authorization due to the high esketamine nasal spray cost and specific administration needs.
Generally, Esketamine is given twice a week during the initial treatment phase, then the frequency is reduced to once a week or every two weeks during maintenance, depending on how the patient responds clinically.
Here’s a clear comparison chart outlining the key differences between ketamine and esketamine:
| Feature | Ketamine (IV Infusion) | Esketamine (Nasal Spray – Spravato) |
| Form | Intravenous (IV) infusion | Nasal spray |
| Composition | Racemic mixture (R- and S-ketamine) | S-ketamine only |
| FDA Approval | Off-label for depression | FDA-approved for treatment-resistant depression |
| Administration Setting | Administered in a clinic under supervision | Administered in a certified clinic under supervision |
| Dosing Control | Highly adjustable, titrated per patient | Esketamine nasal spray dose - Fixed options |
| Onset of Effects | Often rapid (within hours) | Also rapid, typically within hours |
| Cost & Insurance | Often out-of-pocket, not usually covered by insurance | Usually covered by insurance with prior approval |
| Duration of Session | 40–60 minutes infusion, plus recovery time | Shorter administration time, similar monitoring |
| Frequency | Typically 2–3 times per week initially | Usually twice a week to start, then tapered |
| Common Uses | Depression, anxiety, PTSD, chronic pain (off-label) | Treatment-resistant depression, esketamine nasal spray for anxiety |
Both ketamine infusion therapy and esketamine nasal spray (Spravato) are promising options for those battling treatment-resistant depression, often delivering quick relief—sometimes in just a few hours. IV ketamine, which combines both R- and S-ketamine, might offer a bit more strength or consistency and is often preferred for its rapid effect on suicidal thoughts, even though it’s used off-label.
On the other hand, esketamine, which includes only the S-enantiomer, has FDA approval and is generally easier to access through insurance. While both treatments are effective, the best choice really comes down to personal needs, medical history, and the advice of your healthcare provider.
Each of these treatment options, ketamine infusion therapy vs esketamine nasal spray have unique side effects and safety considerations to consider before beginning either treatment.
The most common side effects of ketamine infusion therapy include:
Safety considerations when taking ketamine infusion therapy include:
The most common side effects of esketamine nasal spray include:
Safety considerations when taking esketamine nasal spray include:
The cost and accessibility of ketamine infusion therapy vs esketamine nasal spray varies depending on the clinic or provider you choose to recieve treatment from and your georgraphical location.
Cost and Accessibility of Ketamine Infusion Therapy vs. Esketamine Nasal Spray:
| Aspect | Ketamine Infusion Therapy (IV) | Esketamine Nasal Spray (Spravato) |
| Cost per Treatment | $400–$800+ per infusion (varies by clinic) | $600–$900+ per session (including monitoring fees) |
| Insurance Coverage | Often not covered (off-label use for depression) | Typically covered with prior authorization (FDA-approved) |
| Out-of-Pocket Expenses | Usually 100% unless part of clinical trial | May still have copays, deductibles, or coverage limits |
| Treatment Setting | Private ketamine clinics or specialized centers | Certified REMS (Risk Evaluation and Mitigation Strategy) clinics only |
| Availability | More clinics offer infusions nationwide | Fewer locations due to REMS certification requirements |
| Scheduling Flexibility | Often more flexible—can vary by clinic | More structured, must adhere to strict protocols |
| Accessibility Barriers | Cost, lack of insurance coverage, travel distance | Limited clinic availability, insurance approval process |
When you're weighing the choice between ketamine infusion therapy vs esketamine nasal spray, it's really important to think about a few key factors. These include the cost, whether your insurance will cover it, the treatment environment, and your own medical history. Both treatments can provide quick relief for those struggling with treatment-resistant depression, but they each come with their own set of advantages and drawbacks.
A Telapsychiatry consultation can be a great way to dive deeper into these options with a licensed provider, helping you figure out your eligibility and steering you toward the best and most accessible choice for your mental health journey.
We're here to support you through your journey toward improved mental well-being. Call us at 888-903-5505 or schedule an appointment online
Monday - Friday: 8:00 am - 5:00 pm EST
Closed Saturday & Sunday
